YOLFTbeta
01

Myungmoon Phar

017180 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

1,102.00KRW+5.00 (+0.46%)

Price History

Full chart

Market Stats

Previous Close1,097.00
Open1,107.00
Day Range1,091.00 – 1,107.00
52-Week Range1,000.00 – 2,055.00
Volume10.58K
Market Cap43.02B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.30
50-Day Avg1,216.24
200-Day Avg1,557.48

About

MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally. It offers prescription drugs, including anti osteoarthritis, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxant, anti rheumarthritis, antibiotics and antifungal, respiratory agents, GI therapeutics, circulation agents, anti-hypertension agents, antidiabetic drugs, narcotics, anesthetic agents, central nervous system products, female hormone products, osteoporotic therapeutics, urogentital agents, adrenocortical hormone products, oncology agents, other preparations, and anti-obesity agents for pharmacotherapy. The company also provides OTC products, such as antinausants, genitourinary system products, anti gum disease products, hepatics, parasiticides, cathartic, antidiarrheal agents, digestive system products, multiple vitamin products, eye nutrition products, eye drops, blood circulation products, circulatory solvents, skin external preparations, and topical analgesic products. In addition, it offers health supplements, quasi drugs, and blended juices. MYUNGMOON Pharm co.,Ltd was founded in 1983 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOCheol-han Bae
  • Employees319
  • Headquarters7, Gangnam-daero, Seoul, South Korea, 06258, Korea
  • Websitehttps://www.mmpharm.co.kr

Leadership

  • Mr. Kyu-Huok LeeChairperson & President · b. 1949
  • Cheol-han BaeChief Executive Officer
  • Yong-Kyeong SeongManaging Director and Development Support Director · b. 1964
  • Won-Sann SeoDirector of Chungcheong & Honam Region and Director · b. 1959

Financials

Income Statement

Currency: KRW2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue97.19B105.18B125.62B100.54B103.72B105.42B125.10B142.18B140.14B147.50B149.35B127.85B144.76B152.13B169.57B186.44B195.25B
Growth (%)-+8.22%+19.43%-19.97%+3.17%+1.64%+18.67%+13.65%-1.44%+5.25%+1.25%-14.39%+13.22%+5.09%+11.46%+9.95%+4.72%
Cost of Revenue41.76B45.61B55.15B52.33B51.01B49.41B66.81B66.00B60.93B73.05B80.91B78.86B82.42B74.03B74.21B81.48B88.33B
Gross Profit----47.05B49.65B58.29B76.18B79.20B74.45B68.43B48.99B62.34B78.10B95.35B104.97B106.92B
Gross Margin----45.36%47.10%46.59%53.58%56.52%50.48%45.82%38.32%43.06%51.34%56.23%56.30%54.76%
Operating Expense----42.94B45.92B60.87B66.12B71.73B69.51B82.73B77.96B68.22B71.67B94.39B103.04B100.08B
Operating Income6.77B9.14B11.17B-4.11B3.73B-2.58B10.06B7.47B4.94B-14.29B-28.96B-5.88B6.43B963.77M1.93B6.83B
Operating Margin6.96%8.69%8.89%-3.96%3.53%-2.06%7.07%5.33%3.35%-9.57%-22.65%-4.06%4.23%0.57%1.03%3.50%
EBITDA--------14.49B7.06B-10.94B-18.95B646.44M10.63B4.52B5.67B11.70B
EBITDA Margin--------10.34%4.78%-7.33%-14.82%0.45%6.98%2.67%3.04%5.99%
Net Income2.94B3.07B4.55B-1.03B761.49M-16.14B6.75B7.81B988.27M-20.40B-27.64B-6.86B7.87B-4.52B-3.03B1.90B
Net Income Margin3.03%2.92%3.63%-0.99%0.72%-12.90%4.74%5.57%0.67%-13.66%-21.62%-4.74%5.17%-2.67%-1.63%0.97%
R&D--1.19B-105.31M7.50M23.88M140.58M140.58M140.58M676.47M535.06M2.06B1.71B2.97B2.06B3.99B
R&D as % of Total Revenue--0.94%-0.10%0.01%0.02%0.10%0.10%0.10%0.45%0.42%1.43%1.12%1.75%1.10%2.04%
Interest Expense0000000003.25B4.58B4.14B3.04B3.73B5.14B5.35B5.09B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%2.20%3.07%3.24%2.10%2.45%3.03%2.87%2.61%

Balance Sheet

Currency: KRW2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets153.85B164.15B202.50B188.34B192.41B190.66B199.42B221.08B235.08B243.07B264.44B243.03B222.68B230.45B236.55B257.99B272.46B
Total Liabilities90.02B97.02B119.37B115.47B119.21B117.51B132.30B126.40B133.36B150.00B184.25B152.25B136.80B135.18B147.79B154.87B168.00B
Total Equity58.57B61.40B77.65B67.26B68.49B68.98B63.20B90.99B97.71B89.68B76.51B87.20B80.26B89.52B83.45B96.85B98.74B
Cash4.46B2.52B3.19B2.87B3.09B4.61B2.50B17.63B1.40B622.92M572.14M4.55B6.81B4.86B7.96B4.39B5.84B
Net Debt--------85.81B100.17B115.46B91.86B75.07B76.04B81.14B82.66B91.96B

Cash Flow

Currency: KRW2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-2.87B-2.78B2.00B-36.23M-5.50B5.60B8.02B11.41B-2.94B-16.67B855.00M5.47B-5.18B-1.34B-1.70B
Investing Cash Flow--1.37B--5.49B-302.36M-794.76M-4.72B-27.65B-16.14B-18.97B-661.25M9.08B----
Financing Cash Flow52.29B4.32B-83.51M4.02B1.86B3.88B14.24B2.33B3.95B21.86B21.31B-7.68B----
Capital Expenditure5.74B4.68B2.60B3.66B4.72B2.87B2.66B9.46B18.87B10.93B11.97B2.01B374.71M1.95B2.99B1.40B6.83B
Free Cash Flow---------14.19B313.72M-17.09B-19.11B480.28M3.53B-8.17B-2.74B-8.54B
Dividends Paid483.97M400.21M416.69M472.39M269.96M269.96M312.85M323.61M1.15B2.39B-------
FCF to OCF---------176.86%2.75%581.22%114.62%56.17%64.42%157.73%204.88%500.88%
Dividend Paid to FCF---------8.13%761.77%-------

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Mar 15, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Feb 7, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Mar 17, 2020May 11, 2020Aug 14, 2020Nov 16, 2020Mar 19, 2021May 14, 2021Aug 17, 2021Nov 15, 2021Feb 16, 2022Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022May 15, 2023Aug 11, 2023Nov 14, 2023Mar 20, 2024May 14, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------------------------------------------------
EPS Actual79.9560.6864.42-18.2342.90150.8875.34190.04129.5067.18-84.3943.84-431.69-93.25-82.2330.7346.60-20.42-7.062.2626.61-5.1313.87-25.95-87.9857.04-756.58114.21122.5645.3035.0429.88229.0314.0539.8123.4419.10-19.6816.61-53.76-209.99-56.63-473.74-201.71-387.00-174.00-235.7818.0018.00-4.00-231.5728.5564.372.78137.0417.24-4.05-27.94-120.25-36.21-45.77-23.7415.20-57.79102.70-16.4228.21-23.98-37.72
Surprise---------------------------------------------------------------------
Timing----------------------------------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours----After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours---------

Key Statistics & Ratios

Market Cap43.02B
Enterprise Value104.33B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales0.22
Price / Book0.43
Revenue (TTM)199.82B
Gross Profit (TTM)110.99B
EBITDA5.41B
Profit Margin-0.84%
Operating Margin-1.63%
Return on Equity-2.48%
Return on Assets0.33%
Shares Outstanding33.95M
Shares Float26.10M
Beta0.30
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20171×
95.42Dec 27, 2017
20161×
46.08Dec 28, 2016
20151×
15.21Dec 29, 2015
20141×
14.70Dec 29, 2014
20131×
13.07Dec 27, 2013
20111×
22.82Dec 28, 2011
20101×
26.39Dec 29, 2010
20091×
25.42Dec 29, 2009
20081×
30.51Dec 29, 2008

Stock Splits

  • Jan 3, 20181.0209:1
  • Dec 28, 20161.0355:1
  • Dec 29, 20151.0345:1
  • Dec 29, 20141.0345:1
  • Dec 27, 20131.0302:1
  • Dec 28, 20111.0425:1
  • Jun 14, 20111.1:1
  • Dec 29, 20101.0384:1
  • Dec 29, 20091.0413:1
  • Dec 29, 20081.04:1